Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5525_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Foreword
- •Acknowledgments
- •Editor biographies
- •Yi Wang
- •X. Sharon Qi
- •List of contributors
- •1.2.3 Feature engineering and representation
- •1.2.4 Linear separability
- •1.2.5 Classical models
- •1.1 A brief introduction to AI
- •1.2 Machine learning basics
- •1.2.1 Learning paradigms
- •1.3 Artificial neural networks
- •1.3.1 Feed-forward neural networks
- •1.3.2 Recurrent neural networks
- •1.3.3 Convolutional neural networks
- •1.3.4 Attention
- •1.3.5 Training neural networks
- •1.3.6 Applications and use cases of deep learning
- •1.4 Model training and evaluation
- •1.4.1 Hyperparameters
- •1.4.2 Data split
- •1.4.3 Evaluation metrics
- •1.5 Generative models
- •1.5.1 Generative adversarial networks
- •1.5.2 Diffusion models
- •1.5.3 Applications and use cases
- •1.6 Ethical consideration and bias
- •1.6.1 Transparency and explainability
- •1.6.2 Bias and fairness
- •1.6.3 Data privacy violation
- •1.6.4 Risk and misuse
- •1.7 Summary
- •References
- •2.1 Introduction
- •2.1.2 Staff roles in radiation therapy
- •2.2 Overview of AI in radiation therapy
- •2.2.1 Patient evaluation and dose prescription
- •2.2.2 Treatment simulation
- •2.2.3 Contouring
- •2.2.4 Treatment planning
- •2.2.5 Quality assurance
- •2.2.6 Treatment delivery
- •2.2.7 Response assessment and toxicity management
- •2.3 Summary
- •3.1 Introduction
- •3.1.1 Introduction of clinical decision making and AI
- •3.1.2 The role of AI in clinical decision making
- •3.2 AI algorithms for clinical decision making
- •3.2.2 Radiomics
- •3.2.3 Data integration by AI
- •3.2.4 Interpretability of AI models
- •3.3 Application of AI in clinical decision making
- •3.3.1 Diagnosis and disease phenotyping
- •3.3.2 Personalized treatment
- •3.3.3 Treatment outcome and prognosis prediction
- •3.4 Challenges and future directions of AI in clinical decision making
- •3.4.1 Challenges and concerns
- •3.4.2 Future directions
- •3.5 Summary
- •References
- •4.1 Introduction
- •4.2 Imaging for treatment planning
- •4.2.1 CT simulation
- •4.2.2 4D-CT
- •4.2.3 PET/CT
- •4.2.4 MRI
- •4.3 Imaging for treatment guidance
- •4.3.1 Portal imaging
- •4.3.2 CBCT
- •4.3.3 CT-on-rail and CT-linac
- •4.3.4 MR-linac
- •4.3.5 PET-linac
- •4.4 Imaging for motion management
- •4.4.1 ExacTrac
- •4.4.2 Varian triggered imaging
- •4.4.3 4D-CBCT
- •4.4.4 Cine MRI
- •4.4.5 4D-MRI
- •4.4.6 Surface imaging
- •4.5 Imaging for treatment assessment
- •4.5.1 Contrasted CT
- •4.5.2 PET/CT
- •4.5.3 Functional MRI
- •4.6 Summary
- •5.1 Introduction to big data in radiation oncology
- •5.1.1 Overview of big data
- •5.1.2 Sources of big data in radiation oncology
- •5.1.3 Big data and AI in radiation oncology
- •5.2 Big data lifecycle in radiation oncology
- •5.2.1 Data aggregation and storage
- •5.2.2 Data sharing and security
- •5.4 The application of big data in radiation oncology
- •5.4.1 Medical image segmentation
- •5.4.2 Automatic treatment planning
- •5.4.3 Treatment response prediction
- •5.4.4 Quality assurance and patient safety
- •5.4.5 Clinical decision support
- •5.2.3 Data visualization
- •5.2.4 Knowledge creation and implementation
- •5.2.5 Data archiving and deletion
- •5.3 Big data analytics with AI
- •5.3.1 Data processing and integration
- •5.3.2 AI modeling
- •5.5 Challenges and future perspectives
- •5.6 Summary
- •Reference
- •6.1 The road to ART
- •6.1.1 3D conformal radiotherapy (3DCRT)
- •6.1.2 Intensity modulated radiotherapy (IMRT)
- •6.1.3 Image-guided radiotherapy (IGRT)
- •6.1.4 Adaptive radiotherapy (ART)
- •6.2 ART workflow and implementation
- •6.2.2 Current practice
- •6.2.3 Clinical impact
- •6.3 Considerations for implementing online ART
- •6.3.1 Time as a limiting factor
- •6.3.2 Implications for fast and reliable re-planning
- •6.3.4 Clinical considerations
- •6.4 Summary
- •7.1 Components of ART workflow
- •7.1.1 Simulation
- •7.1.2 Pre-planning
- •7.1.3 Online imaging and daily re-planning
- •7.1.4 Quality assurance
- •7.2 AI-driven ART
- •7.2.1 Simulation
- •7.2.2 Pre-planning
- •7.2.3 AI for delivery
- •7.3 Outlook and future directions
- •7.3.1 Real-time ART with AI
- •7.3.2 Dose escalation and functional adaption with AI
- •7.4 Summary
- •References
- •8.1 Introduction
- •8.2 Synthetic CT: deep learning methods
- •8.2.1 Conventional methods
- •8.2.2 U-Net
- •8.2.3 Generative adversarial networks
- •8.2.4 Denoising diffusion probabilistic model
- •8.3 Synthetic CT from CBCT
- •8.3.1 Noise and artifact reduction
- •8.3.2 Online dose calculation
- •8.3.3 Online image segmentation
- •8.4 Synthetic CT from MRI
- •8.4.1 Synthetic image accuracy
- •8.4.2 Dose calculation in MR-only radiation therapy
- •8.4.3 PET attenuation correction
- •8.4.4 Image registration
- •8.5 Discussion and outlook
- •8.6 Summary
- •References
- •9.1 AI-based image registration and segmentation for ART
- •9.1.1 Adaptive radiation therapy
- •9.2 Artificial intelligence
- •9.2.1 What is machine learning?
- •9.2.2 What is deep learning?
- •9.3 Deep learning: the basic components
- •9.3.1 Convolutional neural networks: looking at the picture
- •9.3.2 Pooling layers: keeping what matters most
- •9.3.3 Fully connected (dense) layers: bringing it all together
- •9.3.4 Activations
- •9.3.5 Loss: driving the model
- •9.3.6 Auto-encoders: remove the noise
- •9.3.7 Supervised versus unsupervised learning
- •9.3.8 Pre-trained convolutional neural networks
- •9.4 Image registration: bringing two images together
- •9.4.1 Registration similarity metrics
- •9.4.2 Types of registrations
- •9.5 AI-based image registration
- •9.5.1 Supervised learning
- •9.5.2 Unsupervised learning
- •9.5.3 Registration in ART
- •9.5.4 Commonalities in architectures
- •9.6 Image segmentation
- •9.6.1 Introduction: coloring by the numbers
- •9.6.2 Segmentation networks
- •9.6.3 Best practices
- •9.7 Summary
- •10.1 Introduction
- •10.1.1 Overview of chapter content
- •10.2 The landscape of AI-assisted dose prediction
- •10.2.1 Traditional machine learning for dose prediction
- •10.2.2 Deep learning-based dose prediction
- •10.2.3 Challenges in AI-assisted dose prediction
- •10.3 Re-planning workflows powered by AI
- •10.3.1 Deep learning for re-planning pipelines
- •10.4 Future directions of AI-assisted dose prediction and re-planning
- •10.5 Summary
- •11.1 Introduction
- •11.2.1 Imaging-based motion monitoring
- •11.2.2 Delivery system actions
- •11.2.3 Challenges for real-time ART implementation
- •11.3 AI in real-time ART workflows
- •11.3.1 Improving intrafraction motion monitoring through AI
- •11.3.2 Mitigating system latency through AI
- •11.4 AI for ART delivery: future directions
- •11.4.1 Management of non-respiratory motion
- •11.4.2 Training AI models with small or unpaired datasets
- •11.4.4 Biology-guided ART delivery
- •11.5 Summary
- •References
- •12.1 Introduction
- •12.2 Patient QA
- •12.2.1 Pre-planning QA
- •12.2.2 Pre-treatment plan QA
- •12.2.3 On-treatment QA
- •12.3 Treatment delivery systems and instruments
- •12.3.1 Machine commissioning
- •12.3.2 Machine QA
- •12.3.3 Dosimetry tool QA
- •12.4 Summary
- •References
- •13.1 Data resources for response modeling in radiotherapy
- •13.1.1 Clinical data
- •13.1.2 Imaging (radiomics)
- •13.1.3 Treatment planning (dosiomics)
- •13.1.4 Multiomics
- •13.2 Radiotherapy treatment outcome modeling
- •13.2.1 TCP/NTCP in radiotherapy
- •13.2.2 Clinical outcomes versus PROs
- •13.2.3 Machine learning response prediction
- •13.2.4 Explainability of ML response models
- •13.2.5 Sample use cases
- •13.3 AI response-based adaptive radiotherapy
- •13.3.1 Requirements and challenges
- •13.3.2 Prediction versus treatment optimization
- •13.3.3 Sample use cases
- •13.4 Challenges and recommendations
- •13.5 Summary
- •Acknowledgments
- •References
- •14.1 Overview of challenges in AI-driven ART
- •14.2 Data challenges
- •14.2.1 Data availability
- •14.2.2 Data quality
- •14.2.3 Data privacy
- •14.3 Technical challenges
- •14.3.2 Model robustness and generalizability
- •14.3.3 Model explainability and interpretability
- •14.4 Challenges associated with online and real-time workflows
- •14.4.1 Image quality
- •14.4.2 Dose calculation
- •14.4.3 Real-time ART
- •14.5 Operational challenges
- •14.5.1 Clinical validation
- •14.5.3 Staff training
- •14.5.4 User experiences
- •14.5.5 Quality management program
- •14.5.6 Financial challenges
- •14.6 Ethical, regulatory, and legal challenges
- •14.6.1 Ethical issues
- •14.6.2 Regulatory and legal issues
- •14.7 Summary
- •References
- •15.1 Clinical considerations for CT-based offline ART
- •15.1.1 Patient and site selection
- •15.1.2 Re-simulation
- •15.1.3 Re-planning
- •15.1.4 Plan summation and evaluation
- •15.1.6 Limitations and future directions
- •15.2 Clinical considerations for CBCT/CT-based online ART
- •15.2.2 Patient and site selection
- •15.2.3 Simulation
- •15.2.4 Pre-planning review
- •15.2.5 Reference planning
- •15.2.9 Limitations and future directions
- •15.3 Summary
- •References
- •16.1 Introduction
- •16.2 Overview of MRI-guided ART systems
- •16.3 MRI-guided ART workflow
- •16.4 AI applications for MRI-guided ART
- •16.4.1 Synthetic CT generation
- •References
- •16.4.2 Auto-segmentation
- •16.4.3 Image registration
- •16.4.4 Others
- •16.4.5 Future AI development and implementation
- •16.5 Summary
- •17.1 Functional PET-guided ART
- •17.1.1 PET-based functional imaging overview
- •17.1.2 From anatomy to function: the power of PET in radiation therapy
- •17.1.5 Conclusions and future prospects
- •17.2 Functional MRI-guided ART
- •17.2.1 From anatomy to function: the power of functional MRI in radiation therapy
- •17.2.4 Conclusion and future prospects
- •17.3 Summary
- •References
- •18.1 Proton ART
- •18.1.1 Clinical context and necessity
- •18.1.2 Patient populations
- •18.1.4 Rationale for AI in proton ART
- •18.2 AI in proton ART
- •18.2.1 Imaging
- •18.2.2 Deformable and rigid registration
- •18.2.3 Contour propagation
- •18.2.4 Dose calculations
- •18.2.5 Plan optimization
- •18.2.6 Other developments
- •18.3 Implementation of adaptive proton therapy
- •18.4 Summary
- •References
- •19.1 Designing clinical trials with AI
- •19.1.1 The essential role of clinical trials
- •19.1.2 Trial protocols and methodologies
- •19.1.3 AI-driven clinical trial design and execution
- •19.1.4 Incorporation of digital twins (DTs) in clinical trials
- •19.2 Implementation of AI in ongoing clinical trials
- •19.2.1 Integration with existing clinical trial frameworks
- •19.2.2 Quality assurance, compliance, and standardization
- •19.3 Case studies of AI in adaptive radiotherapy trials
- •19.3.1 Overview of guidance for advanced radiotherapy in clinical trials
- •19.3.2 AI in the radiotherapy clinical trial quality assurance processes
- •19.4 Ethical and regulatory considerations
- •19.4.1 Patient consent and data privacy
- •19.4.2 Bias, fairness, and transparency
- •19.4.3 Regulatory guidelines and compliance
- •19.5 Future directions and challenges
- •19.5.1 Emerging technologies and techniques
- •19.5.2 Alternative strategies
- •19.6 Conclusion
- •19.7 Summary
- •References
- •20.1 Risk management
- •20.1.1 Prospective risk assessments
- •20.1.2 Root cause analysis

Artificial Intelligence in Adaptive Radiation Therapy
10.3.1 Deep learning for re-planning pipelines
10.3.1.1 Automatic segmentations
Figure 10.5 places auto-segmentation, the topic of chapter 9, near the start of the
workflow, illustrating its relevance. This important step currently benefits from deep
learning, even in commercial systems. Since segmented structures serve as inputs to
subsequent steps in the ART workflow, including re-planning, accurate tools for fast
automatic segmentation are essential. In the last decade, medical image segmentation powered by AI has made remarkable progress, significantly outpacing other
areas integrating AI, including dose prediction. This advancement is supported by
the availability of numerous curated datasets and performance evaluation schemes
for both researchers and enthusiasts. While progress will likely continue at an
accelerated pace, evidence already exists for cases where auto-segmentation tools
matched human performance [96]. Furthermore, these tools have also demonstrated
inherent reductions in both interobserver variability and the time needed for this
labor-intensive and time-consuming step [96, 97].
10.3.1.2 From dose prediction to deliverable plans
Figure 10.6 illustrates a hypothetical scenario where deep learning is integrated into
the re-planning process, with a primary focus on dose prediction. Before predicting
the dose, three essential deep learning applications come into play: generating a set
of structures (see figure 10.5), estimating the orientation of treatment beams when
applicable, and predicting a suitable dose distribution using the outputs of the
previous two steps. By integrating these deep learning components together, each
with the potential for exceptional performance and a high degree of automation, the
pipeline becomes highly autonomous and fast.
Predicting beam orientation, when relevant to the treatment, offers several
benefits. For example, it eliminates the need for a planner to search for an optimal
beam configuration, saving time. As with dose prediction, automating this step can
potentially enhance consistency in plan quality. Using beam geometry information
during dose prediction can also lead to gains in prediction accuracy [49, 76, 82].
Figure 10.6. Flowchart depicting four potential applications of deep learning (indicated by the red outlines)
that could be integrated into re-planning pipelines for online and offline ART.
10-13

Artificial Intelligence in Adaptive Radiation Therapy
Researchers have successfully employed deep learning for automatic beam angle
selection in applications for intensity-modulated radiation therapy (IMRT) and
intensity-modulated proton therapy (IMPT) [98, 99].
Once the dose is predicted based on the desired anatomical information, it serves
as a guide for the optimization process, ultimately leading to a deliverable dose that
meets the clinical objectives for the treatment. The feasibility of using deep learningbased dose prediction to guide plan optimization has been demonstrated in several
studies [39, 48, 77]. Additionally, Mahmood et al showed that the deliverable dose
obtained from optimizing based on deep learning-predicted doses was better at
creating plans that met clinical criteria compared to state-of-the-art knowledgebased planning methods using traditional machine learning and other classical
techniques [39].
Another promising application of deep learning is fluence map prediction, which
involves generating a fluence map from a dose distribution [29, 100, 101]. The aim of
this application is to bypass the need for a separate optimization step. By combining
fluence map prediction with dose and angle prediction, a deep learning-based
algorithm could generate all the necessary treatment parameters in a single step,
potentially resulting in a tremendous reduction in planning time.
Although the approaches mentioned here could plausibly result in highly
accelerated re-planning, it is worth noting that they all represent areas of active
research. While significant progress has been made in recent years, there are still
challenges to overcome before these techniques can be fully and safely integrated
into clinical workflows.
10.3.1.3 Virtualizing the re-planning process with deep reinforcement learning
(DRL)
One of the potential final steps of the flowchart in figure 10.6 shows the use of DRL
to automate and expedite re-planning. DRL is a subfield of deep learning, which has
been proposed as a tool for mimicking the human decision-making process during
treatment planning [102–104]. The resulting networks, known as virtual treatment
planner networks (VTPNs), are trained to intelligently tune the treatment planning
system by making reasonable parameter adjustments to achieve high-quality plans.
In practice, these networks monitor intermediate DVH curves for a developing plan
and decide how to improve the plan by adjusting weights and threshold doses in the
objective function.
Shen et al demonstrated the potential of this approach by training a VTPN on a
small dataset of just 10 patients [103 ]. When applied to a test patient cohort, the
trained network led to a substantial increase in plan quality. A subsequent study by
Sprouts et al further highlighted the ability of VTPNs to improve plan quality and
efficiency [104]. On average, the trained VTPN took less than one minute to reach
the final treatment plan for each case using their in-house treatment planning system
(TPS), while an experienced human planner required about three minutes to finish
the same planning steps. These early applications of reinforcement learning suggest
that by virtualizing the planning process, the speed and efficiency of deep learning
10-14

Artificial Intelligence in Adaptive Radiation Therapy
can be leveraged to produce human-like results in a fraction of the time needed by
human planners.
10.3.1.4 Anticipating change: deep learning for predicting anatomical variations
In addition to speeding up the planning process, deep learning tools could help in
forecasting future anatomical changes for a patient. This possibility is indicated with
a process at the start of figure 10.6. The result of such an algorithm, which serves as
input to the subsequent steps of the flowchart, represents information that can
facilitate the generation of a set of plans with deliverable dose distributions. This
approach would resemble the ‘plan-of-the-day’ scheme used in some offline ART
applications [92, 105 ]. In cases where the anatomical changes are accurately
forecasted and a plan is ready, treatment can begin without delay or with minimal
initial adjustments. The ability to use deep learning to forecast anatomical changes
and potentially create corresponding plans with improved normal tissue sparing
showed promise in a recent study [106]. Lee et al used a sequence-to-sequence
(Seq2Seq) technique based on convolutional long short-term memory (Conv-LSTM)
to predict the longitudinal changes of the esophagus and lung tumor.
10.3.1.5 Summary of deep learning for re-planning pipelines
While the scenarios discussed in relation to figure 10.6 are hypothetical, they are
grounded in recent research findings. However, it is challenging to predict with
certainty which techniques and ideas will drive the ART workflows of the future,
particularly in fields well-positioned to benefit from the rapidly advancing domain of
deep learning.
In our discussion, we omitted the quality assurance steps. Deep learning has led to
impressive outcomes in applications pertinent to quality assurance, e.g. a tool for
sub-second Monte Carlo calculations and similarly fast statistical robustness
evaluation of IMPT dose distributions [107, 108]. The omission of these steps
does not imply the unlikely ideal case of error-free performance by the discussed
deep learning implementations. Indeed, if these methods were implemented, several
quality control checks would be necessary to assess their performance and alert
clinicians when errors or other unwanted circumstances are likely to occur.
10.4 Future directions of AI-assisted dose prediction and re-planning
Deep learning-based dose prediction is a growing field with a lot of untapped
potential. The impressive performance of these techniques and their ability to
automate tasks create many new possibilities. Figure 10.7 shows one such possibility, displaying two dose prediction outputs for a patient: one for a VMAT photon
treatment and one for an IMPT treatment. This kind of volumetric dose information, combined with DVH metrics, could help clinicians compare different treatment
modalities before starting formal treatment planning process. This can also benefit
in situations when treatment machines become unavailable due to unforeseen
circumstances, allowing for quick adaptations and minimizing treatment delays.
10-15

Artificial Intelligence in Adaptive Radiation Therapy
Figure 10.7. Comparison of two treatment modalities for the same patient. The left panel shows dose
distributions predicted by a deep learning model for a VMAT plan (left) and IMPT plan (right).
Another example is real-time re-planning, which could be achieved with the help
of dose prediction algorithms based on high-speed imaging techniques such as those
in MRI-guided radiotherapy. In addition, accurate dose prediction using cone-beam
CT could provide a useful quality assurance tool in online ART pipelines.
Dose prediction and deep learning methods for re-planning may also see
significant performance improvements, driven by emerging trends such as the use
of transformers [109, 110]. Transformer models have achieved remarkable success in
natural language processing and computer vision tasks. These architectures excel at
handling long-range dependencies and capturing complex spatial relationships,
potentially helping achieve new state-of-the-art performance.
Future initiatives to advance collaboration and increase the availability of
standardized, high-quality data will be essential in driving the development and
validation of AI-assisted dose prediction and re-planning tools. Establishing shared
datasets and benchmarks can facilitate the comparison and improvement of different models, while also promoting transparency and reproducibility in research.
Collaborative efforts among institutions and researchers can accelerate this progress
and ensure that the benefits of these technologies are widely accessible to the
radiotherapy community.
Looking ahead, the next steps in AI-powered dose prediction and re-planning will
require close collaboration among medical physicists, radiation oncologists, computer scientists, and industry partners. Continued research and development efforts
are needed to refine AI models, integrate them into clinical workflows, and evaluate
their impact on patient outcomes. By embracing the potential of AI and working
towards its responsible and effective implementation, the radiotherapy community
can bring about a new era of personalized, adaptive, and precise cancer care.
10.5 Summary
The integration of artificial intelligence, particularly deep learning, into adaptive
radiation therapy workflows can have a profound impact on the field of radiation
10-16

Artificial Intelligence in Adaptive Radiation Therapy
oncology. AI-assisted dose prediction and re-planning techniques offer promising
solutions to some of the challenges associated with traditional radiotherapy
planning, such as reducing time for otherwise laborious manual processes, increasing
consistency in plan quality, and enabling rapid adaptations in response to anatomical changes.
Deep learning-based dose prediction methods have demonstrated remarkable
accuracy and speed in estimating volumetric dose distributions across various
anatomical sites and treatment modalities. These AI-powered tools can streamline
the planning process by providing valuable guidance to clinicians as they aim to
create safe and effective treatment plans.
The continued advancement of AI-assisted dose prediction and re-planning
hinges on several key areas. The development of standardized datasets and
evaluation metrics will be crucial for establishing benchmarks and facilitating
meaningful comparisons between different models. Encouraging collaboration
among institutions to share knowledge and data will accelerate progress and
mitigate potential biases. Additionally, the exploration of innovative deep learning
architectures and training strategies holds the promise of unlocking even greater
levels of performance and automation. Crucially, addressing the challenges associated with clinical implementation, such as ensuring robust quality control and
enhancing the interpretability of AI-generated outcomes, will be necessary to
guarantee the safe and effective deployment of these tools in real-world healthcare
settings.
The future of AI in adaptive radiation therapy holds immense promise, and much
is left to be discovered. To fully harness the potential of AI-assisted dose prediction
and re-planning, close collaboration among medical physicists, radiation oncologists, computer scientists, and industry partners is essential. As we look ahead,
embracing the transformative power of AI in radiation oncology will be key to
improving treatment efficacy, enhancing patient outcomes, and ultimately, advancing the fight against cancer.
References
[1] Yan D, Vicini F, Wong J and Martinez A 1997 Adaptive radiation therapy Phys. Med.
Biol.
42 123–32
[2] Nguyen D, Lin M H, Sher D, Lu W, Jia X and Jiang S 2022 Advances in automated
treatment planning Semin. Radiat. Oncol.
[3] Paganetti H, Botas P, Sharp G C and Winey B 2021 Adaptive proton therapy Phys. Med.
Biol.
66 22TR01
[4] Brock K K 2019 Adaptive radiotherapy: moving into the future Semin. Radiat. Oncol. 29
181–4
[5] Das I J, Moskvin V and Johnstone P A 2009 A nalysis of treatment planning time among
systems and planners for intensity-modulated radiation therapy J. Am. Coll. Radiol.
514–7
[6] Khan F M, Gibbons J P and Sperduto P W 2021 Khan’s Treatment Planning in Radiation
Oncology (Waltham, MA: Wolters Kluwer Health)
32 343–50
10-17
6

Artificial Intelligence in Adaptive Radiation Therapy
[7] Videtic G M, Vassil A D and Woody N M 2020 Handbook of Treatment Planning in
Radiation Oncology (Berlin: Springer)
[8] Kishan A U, Cui J, Wang P C, Daly M E, Purdy J A and Chen A M 2014 Quantification of
gross tumour volume changes between simulation and first day of radiotherapy for patients
with locally advanced malignancies of the lung and head/neck J. Med. Imaging. Radiat.
Oncol.
58 618–24
[9] Scaggion A, Fusella M, Roggio A, Bacco S, Pivato N, Rossato M A, Peña L M A and
Paiusco M 2018 Reducing inter- and intra-planner variability in radiotherapy plan output
with a commercial knowledge-based planning solution Phys. Med.
[10] Moore K L et al 2015 Quantifying unnecessary normal tissue complication risks due to
suboptimal planning: a secondary study of RTOG 0126 Int. J. Radiat. Oncol. Biol. Phys.
228–35
[11] Nelms B E, Robinson G, Markham J, Velasco K, Boyd S, Narayan S, Wheeler J and
Sobczak M L 2012 Variation in external beam treatment plan quality: an inter-institutional
study of planners and planning systems Pract. Radiat. Oncol.
[12] Momin S, Fu Y, Lei Y, Roper J, Bradley J D, Curran W J, Liu T and Yang X 2021
Knowledge-based radiation treatment planning: a data-driven method survey J. Appl. Clin.
Med. Phys.
[13] Shiraishi S and Moore K L 2016 Knowledge-based prediction of three-dimensional dose
distributions for external beam radiotherapy Med. Phys.
[14] Kui X, Liu F, Yang M, Wang H, Liu C, Huang D, Li Q, Chen L and Zou B 2024 A review
of dose prediction methods for tumor radiation therapy Meta Radiol.
[15] Glide-Hurst C K et al 2021 Adaptive radiation therapy (ART) strategies and technical
considerations: a state of the ART review from NRG oncology Int. J. Radiat. Oncol. Biol.
Phys.
[16] Fuglsang Jensen M and Witt Nystrom P 2020 Treatment planning for proton therapy: what
is needed in the next 10 years? Br. J. Radiol.
[17] Wang M, Zhang Q, Lam S, Cai J and Yang R 2020 A review on application of deep
learning algorithms in external beam radiotherapy automated treatment planning Front.
Oncol.
[18] Fogliata A, Cozzi L, Reggiori G, Stravato A, Lobefalo F, Franzese C, Franceschini D,
Tomatis S and Scorsetti M 2019 RapidPlan knowledge based planning: iterative learning
process and model ability to steer planning strategies Radiat. Oncol.
[19] Huang K et al 2024 Automatic end-to-end VMAT treatment planning for rectal cancers
J. Appl. Clin. Med. Phys.
[20] Creemers I H P, Kusters J M A M, van Kollenburg P G M, Bouwmans L C W, Schinagl
D A X and Bussink J 2019 Comparison of dose metrics between automated and manual
radiotherapy planning for advanced stage non-small cell lung cancer with volumetric
modulated arc therapy Phys. Imaging. Radiat. Oncol.
[21] van Gysen K, O’Toole J, Le A, Wu K, Schuler T, Porter B, Kipritidis J, Atyeo J, Brown C
and Eade T 2020 Rolling out RapidPlan: what we’ve learnt J. Med. Radiat. Sci.
[22] Rhee D J, Jhingran A, Kisling K, Cardenas C, Simonds H and Court L 2020 Automated
radiation treatment planning for cervical cancer Semin. Radiat. Oncol.
[23] Lecun Y, Bengio Y and Hinton G 2015 Deep learning Nature 521 436–44
[24] Abadi M et al 2016 TensorFlow: large-scale machine learning on heterogeneous distributed
systems arXiv:
22 16–44
43 378–87
109 1054–75
93 20190304
10 580919
25 e14259
9 92–6
1603.04467
53 86–93
92
2 296–305
2 100057
14 187
67 310–7
30 340–7
10-18

Artificial Intelligence in Adaptive Radiation Therapy
[25] Paszke A et al 2019 PyTorch: an imperative style, high-performance deep learning library
arXiv: 1912.01703v1
[26] Kajikawa T, Kadoya N, Ito K, Takayama Y, Chiba T, Tomori S, Nemoto H, Dobashi S,
Takeda K and Jingu K 2019 A convolutional neural network approach for IMRT dose
distribution prediction in prostate cancer patients J. Radiat. Res.
[27] Kearney V, Chan J W, Haaf S, Descovich M and Solberg T D 2018 DoseNet: a volumetric
dose prediction algorithm using 3D fully-convolutional neural networks Phys. Med. Biol.
63 235022
[28] Kontaxis C, Bol G H, Lagendijk J J W and Raaymakers B W 2020 DeepDose: towards a
fast dose calculation engine for radiation therapy using deep learning Phys. Med. Biol.
075013
[29] Li X, Zhang J, Sheng Y, Chang Y, Yin F F, Ge Y, Wu Q J and Wang C 2020 Automatic
IMRT planning via static field fluence prediction (AIP-SFFP): a deep learning algorithm
for real-time prostate treatment planning Phys. Med. Biol.
[30] Nguyen D, McBeth R, Sadeghnejad Barkousaraie A, Bohara G, Shen C, Jia X and Jiang S
2020 Incorporating human and learned domain knowledge into training deep neural
networks: a differentiable dose–volume histogram and adversarial inspired framework for
generating Pareto optimal dose distributions in radiation therapy Med. Phys.
[31] Wang W, Chang Y, Liu Y, Liang Z, Liao Y, Qin B, Liu X and Yang Z 2022 Feasibility
study of fast intensity-modulated proton therapy dose prediction method using deep neural
networks for prostate cancer Med. Phys.
[32] Wang J, Hu J, Song Y, Wang Q, Zhang X, Bai S and Yi Z 2022 VMAT dose prediction in
radiotherapy by using progressive refinement UNet Neurocomputing
[33] Ma J, Nguyen D, Bai T, Folkerts M, Jia X, Lu W, Zhou L and Jiang S 2021 A feasibility
study on deep learning-based individualized 3D dose distribution prediction Med. Phys.
4438–47
[34] Liu J, Zhang X, Cheng X and Sun L 2024 A deep learning-based dose prediction method
for evaluation of radiotherapy treatment planning J. Radiat. Res. Appl. Sci.
[35] Chen X, Men K, Li Y, Yi J and Dai J 2019 A feasibility study on an automated method to
generate patient-specific dose distributions for radiotherapy using deep learning Med. Phys.
46 56–64
[36] Chen X, Men K, Zhu J, Yang B, Li M, Liu Z, Yan X, Yi J and Dai J 2021 DVHnet: a deep
learning-based prediction of patient-specific dose volume histograms for radiotherapy
planning Med. Phys.
[37] Liu Z, Chen X, Men K, Yi J and Dai J 2020 A deep learning model to predict dose–volume
histograms of organs at risk in radiotherapy treatment plans Med. Phys.
[38] Zhang G, Jiang Z, Zhu J and Wang L 2022 Dose prediction for cervical cancer VMAT
patients with a full-scale 3D-cGAN-based model and the comparison of different input data
on the prediction results Radiat. Oncol.
[39] Mahmood R, Babier A, McNiven A, Diamant A and Chan T C Y 2018 Automated
treatment planning in radiation therapy using generative adversarial networks Proc. Mach.
Learn. Res 85 484–99
[40] Mao X, Pineau J, Keyes R and Enger S A 2020 RapidBrachyDL: rapid radiation
dose calculations in brachytherapy via deep learning Int. J. Radiat. Oncol. Biol. Phys.
108 802–12
48 2705–13
49 5451–63
17 179
60 685–93
65
65 175014
47 837–49
488 528–39
48
17 100757
47 5467–81
10-19

Artificial Intelligence in Adaptive Radiation Therapy
[41] McIntosh C, Welch M, McNiven A, Jaffray D A and Purdie T G 2017 Fully automated
treatment planning for head and neck radiotherapy using a voxel-based dose prediction and
dose mimicking method Phys. Med. Biol.
[42] Maniscalco A, Liang X, Lin M H, Jiang S and Nguyen D 2023 Intentional deep overfit
learning for patient-specific dose predictions in adaptive radiotherapy Med. Phys.
5354–63
[43] Nguyen D, Sadeghnejad Barkousaraie A, Bohara G, Balagopal A, McBeth R, Lin M H
and Jiang S 2021 A comparison of Monte Carlo dropout and bootstrap aggregation on the
performance and uncertainty estimation in radiation therapy dose prediction with deep
learning neural networks Phys. Med. Biol.
[44] Osman A F I, Tamam N M and Yousif Y A M 2023 A comparative study of deep learning-
based knowledge-based planning methods for 3D dose distribution prediction of head and
neck J. Appl. Clin. Med. Phys.
[45] Nguyen D, Jia X, Sher D, Lin M H, Iqbal Z, Liu H and Jiang S 2019 3D radiotherapy dose
prediction on head and neck cancer patients with a hierarchically densely connected U-Net
deep learning architecture Phys. Med. Biol.
[46] Liu S, Zhang J, Li T, Yan H and Liu J 2021 Technical note: a cascade 3D U-Net for dose
prediction in radiotherapy Med. Phys.
[47] Zimmermann L, Faustmann E, Ramsl C, Georg D and Heilemann G 2021 Technical note:
dose prediction for radiation therapy using feature-based losses and one cycle learning
Med. Phys.
[48] Fan J, Wang J, Chen Z, Hu C, Zhang Z and Hu W 2019 Automatic treatment planning
based on three-dimensional dose distribution predicted from deep learning technique
Med. Phys.
[49] Barragán-Montero A M, Nguyen D, Lu W, Lin M H, Norouzi-Kandalan R, Geets X,
Sterpin E and Jiang S 2019 Three-dimensional dose prediction for lung IMRT patients
with deep neural networks: robust learning from heterogeneous beam configurations
Med. Phys.
[50] Shao Y, Zhang X, Wu G, Gu Q, Wang J, Ying Y, Feng A, Xie G, Kong Q and Xu Z 2021
Prediction of three-dimensional radiotherapy optimal dose distributions for lung cancer
patients with asymmetric network IEEE J. Biomed. Health Inform.
[51] Jihong C, Penggang B, Xiuchun Z, Kaiqiang C, Wenjuan C, Yitao D, Jiewei Q, Kerun Q,
Jing Z and Tianming W 2020 Automated intensity modulated radiation therapy treatment
planning for cervical cancer based on convolution neural network Technol. Cancer Res.
Treat.
[52] Gronberg M P et al 2023 Deep learning-based dose prediction to improve the plan quality
of volumetric modulated arc therapy for gynecologic cancers Med. Phys.
[53] Ahn S H et al 2021 Deep learning method for prediction of patient-specific dose distribution
in breast cancer Radiat. Oncol.
[54] Bakx N, Bluemink H, Hagelaar E, van der Sangen M, Theuws J and Hurkmans C 2021
Development and evaluation of radiotherapy deep learning dose prediction models for
breast cancer Phys. Imaging Radiat. Oncol.
[55] Lin T C, Lin C Y, Li K C, Ji J H, Liang J A, Shiau A C, Liu L C and Wang T H 2020
Automated hypofractionated IMRT treatment planning for early-stage breast cancer
Radiat. Oncol.
48 5562–6
46 370–81
46 3679–91
19
15 67
24 e14015
16 154
62 5926–44
50
66 054002
64 065020
48 5574–82
25 1120–7
50 6639–48
17 65–70
10-20

Artificial Intelligence in Adaptive Radiation Therapy
[56] Babier A, Zhang B, Mahmood R, Moore K L, Purdie T G, McNiven A L and Chan T C Y
2021 OpenKBP: the open-access knowledge-based planning grand challenge and dataset
Med. Phys.
[57] Ronneberger O, Fischer P and Brox T 2015 U-Net: convolutional networks for biomedical
image segmentation arXiv:
[58] Gronberg M P, Gay S S, Netherton T J, Rhee D J, Court L E and Cardenas C E 2021
Technical note: dose prediction for head and neck radiotherapy using a three-dimensional
dense dilated U-Net architecture Med. Phys.
[59] Chun J, Park J C, Olberg S, Zhang Y, Nguyen D, Wang J, Kim J S and Jiang S 2022
Intentional deep overfit learning (IDOL): a novel deep learning strategy for adaptive
radiation therapy Med. Phys.
[60] Maniscalco A, Liang X, Lin M H, Jiang S and Nguyen D 2023 Single patient learning for
adaptive radiotherapy dose prediction Med. Phys.
[61] Çiçek Ö, Abdulkadir A, Lienkamp S S, Brox T and Ronneberger O 2016 3D U-Net:
learning dense volumetric segmentation from sparse annotation Medical Image Computing
and Computer-Assisted Intervention
Springer)
[62] Nguyen D, Long T, Jia X, Lu W, Gu X, Iqbal Z and Jiang S 2019 A feasibility study for
predicting optimal radiation therapy dose distributions of prostate cancer patients from
patient anatomy using deep learning Sci. Rep.
[63] Kearney V, Chan J W, Wang T, Perry A, Descovich M, Morin O, Yom S S and Solberg T D
2020 DoseGAN: a generative adversarial network for synthetic dose prediction using
attention-gated discrimination and generation Sci. Rep.
[64] Kearney V, Chan J W, Wang T, Perry A, Yom S S and Solberg T D 2019 Attention-
enabled 3D boosted convolutional neural networks for semantic CT segmentation using
deep supervision Phys. Med. Biol.
[65] Oktay O et al 2018 Attention U-Net: learning where to look for the pancreas arXiv:
1804.03999
[66] Soomro M H, Gabriel V, Alves L, Nourzadeh H and Siebers J V 2021 DeepDoseNet: a
deep learning model for 3D dose prediction in radiation therapy arXiv:
[67] He K, Zhang X, Ren S and Sun J 2016 Identity mappings in deep residual networks arXiv:
1603.05027
[68] Huang G, Liu Z, van der Maaten L and Weinberger K Q 2017 Densely connected
convolutional networks Proc. of the IEEE Conf. on Computer Vision and Pattern
Recognition (Piscataway, NJ: IEEE)
[69] Zhang J, Liu S, Yan H, Li T, Mao R and Liu J 2020 Predicting voxel-level dose
distributions for esophageal radiotherapy using densely connected network with dilated
convolutions Phys. Med. Biol.
[70] Yu F and Koltun V 2015 Multi-scale context aggregation by dilated convolutions arXiv:
1511.07122
[71] Yu F, Koltun V and Funkhouser T 2017 Dilated residual networks 2017 IEEE Conf. on
Computer Vision and Pattern Recognition (Piscataway, NJ: IEEE)
[72] Nair V and Hinton G E 2010 Rectified linear units improve restricted Boltzmann machines
Proc. of the 27th Int. Conf. on Machine Learning (ICML-10) pp 807–14
[73] Misra D 2019 Mish: a self regularized non-monotonic activation function arXiv:
1908.08681
48 5549–61
1505.04597
48 5567–73
49 488–96
50 7324–37
Lecture Notes in Computer Science vol 9901 (Cham:
9 1076
10 11073
64 135001
2111.00077
65 205013
10-21

Artificial Intelligence in Adaptive Radiation Therapy
[74] Ioffe S and Szegedy C 2015 Batch normalization: sccelerating deep network training by
reducing internal covariate shift Proc. Mach. Learn. Res. 37 448–56
[75] Wu Y and He K 2018 Group normalization Proc. of the European Conf. on Computer
Vision (ECCV) pp 3–19
[76] Gao R, Lou B, Xu Z, Comaniciu D and Kamen A 2023 Flexible-C m GAN: towards
precise 3D dose prediction in radiotherapy Proc. of the IEEE/CVF Conf. on Computer
Vision and Pattern Recognition (Piscataway, NJ: IEEE)
[77] Babier A, Mahmood R, McNiven A L, Diamant A and Chan T C Y 2020 Knowledge-
based automated planning with three-dimensional generative adversarial networks Med.
Phys.
47 297–306
[78] Tran D, Wang H, Torresani L, Ray J, Lecun Y and Paluri M 2018 A closer look at
spatiotemporal convolutions for action recognition Proc. of the IEEE Computer Society
Conf. on Computer Vision and Pattern Recognition (Los Alamitos, CA: IEEE Computer
Society) pp 6450–9
[79] Isensee F et al 2018 nnU-Net: self-adapting framework for U-Net-based medical image
segmentation Bildverarbeitung für die Medizin (Wiesbaden: Springer Vieweg)
[80] Mashayekhi M, Tapia I R, Balagopal A, Zhong X, Barkousaraie A S, McBeth R, Lin M H,
Jiang S and Nguyen D 2022 Site-agnostic 3D dose distribution prediction with deep
learning neural networks Med. Phys.
[81] Yue M, Xue X, Wang Z, Lambo R L, Zhao W, Xie Y, Cai J and Qin W 2022 Dose
prediction via distance-guided deep learning: initial development for nasopharyngeal
carcinoma radiotherapy Radiother. Oncol.
[82] Zhang L et al 2023 Beam mask and slidi ng window-facilitated deep learning-based
accurate and efficient dose prediction for pencil beam scanning proton therapy
Med. Phys.
[83] Zhou J, Peng Z, Song Y, Chang Y, Pei X, Sheng L and Xu X G 2020 A method of using
deep learning to predict three-dimensional dose distributions for intensity-modulated
radiotherapy of rectal cancer J. Appl. Clin. Med. Phys.
[84] Bai X, Zhang J, Wang B, Wang S, Xiang Y and Hou Q 2021 Sharp loss: a new loss function
for radiotherapy dose prediction based on fully convolutional networks Biomed. Eng.
Online
[85] Jhanwar G, Dahiya N, Ghahremani P, Zarepisheh M and Nadeem S 2022 Domain
knowledge driven 3D dose prediction using moment-based loss function Phys. Med. Biol.
67 185017
[86] Kandalan R N, Nguyen D, Rezaeian N H, Barragán-Montero A M, Breedveld S,
Namuduri K, Jiang S and Lin M H 2020 Dose prediction with deep learning for prostate
cancer radiation therapy: model adaptation to different treatment planning practices
Radiother. Oncol.
[87] Chen T, Goodfellow I and Shlens J 2015 Net2Net: accelerating learning via knowledge
transfer arXiv:
[88] Sahoo D, Pham Q, Lu J and Hoi S C H 2017 Online deep learning: learning deep neural
networks on the fly arXiv:1 711.03705
[89] Baroudi H et al 2023 Automated contouring and planning in radiation therapy: what is
‘clinically acceptable’? Diagnostics
[90] McIntosh C et al 2021 Clinical integration of machine learning for curative-intent radiation
treatment of patients with prostate cancer Nat. Med.
51 1484–98
20 101
153 228–35
1511.05641
49 1391–406
170 198–204
21 26–37
13 667
27 999–1005
10-22
Соседние файлы в папке Библиотека им академика М.И. Перельмана
